课题基金 / 基金详情

DOUBLE BLIND PLACEBO CONTROLLED STUDY OF DMP 266 AND INDINVIR IN HIV+ PATIENTS

DOUBLE BLIND PLACEBO CONTROLLED STUDY OF DMP 266 AND INDINVIR IN HIV+ PATIENTS
DMP 266 和 Indinvir 在 HIV 患者中的双盲安慰剂对照研究
批准号：
6275795
负责人：
SHARON RIDDLER
金额：
$1.91万
依托单位：
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6275795
关键词：
HIV infections antiAIDS agent clinical research clinical trial phase I drug screening /evaluation human subject human therapy evaluation microorganism disease chemotherapy pharmacokinetics

项目摘要

项目成果

SHARON RIDDLER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The primary objective of this study is to evaluate antiretroviral activity of DMP 266 alone and in combination with indinavir in asymptomatic or mildly symptomatic HIV-infected patients. Secondary objectives are to assess pharmacokinetics of multiple doses as single agent and determine if there is a pharmacokinetics interaction between indinavir and DMP266.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Native-like Envelope Trimer Therapeutic Vaccination for Induction of Broadly Neutralizing Antibodies to Facilitate HIV Functional Cure
Native-like Envelope Trimer Therapeutic Vaccination for Induction of Broadly Neutralizing Antibodies to Facilitate HIV Functional Cure
Native-like Envelope Trimer Therapeutic Vaccination for Induction of Broadly Neutralizing Antibodies to Facilitate HIV Functional Cure
AN ASSESSMENT OF ORAL MUCOSAL IMMUNITY IN HIV-1 INFECTION - VERSION 10
海外基金